Real-world performance and safety of Cerviron® medical device in the treatment of various types of vaginitis

A collection of clinical data was conducted to assess the performance and tolerability of Cerviron ® ovules in the treatment and management of various types of vaginitis in clinical practice. A total of 111 women aged between 20 and 70 years were included, 71 of whom were treated with Cerviron ® ovules as monotherapy and 40 who used Cerviron ® ovules as supportive treatment in conjunction with antibiotic therapy. The aim of our study was to assess the relief in vaginal symptoms and changes in the normal vaginal pH level after 3 months of treatment with Cerviron ® medical device in real-life clinical practice settings. The results showed that Cerviron ® ovules are well tolerated and effective as monotherapy and also as an adjuvant to antibiotic therapy. The study and its details are registered in www.clinicaltrials.gov under ID NCT05652959 .